Viking Therapeutics shares fall 40% on disappointing obesity pill trial data

Viking Therapeutics shares fall 40% on disappointing obesity pill trial data - CNBC

Business

4 minutes 8 Views 05 Comment 1.5k Share

Shares of Viking Therapeutics plunged Tuesday after the company released midstage trial data on its obesity pill that disappointed investors.? The biotech company's stock price dropped to about $23.? [+2885 chars]

Annika Kim Constantino

Read Full Article View All Articles

Comments

No comments yet. Be the first to comment!

Popular Categories

Business

Stay Connected

13,977 Fans 21,798 Followers 7,999 Subscribers 19,764 Followers 31,999 Connections 5,000 Followers 9,000 Subscribers 18,000 Followers 2,500 Karma Join Chat Join Channel

Share:

Annika Kim Constantino

Leave A Comment

Comments

Popular Categories

Stay Connected

Get In Touch

Recent Posts

Categories

Our Gallary